The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (376.51) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -25713.2%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 25713.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.4% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (730.36) - (256.99) | (376.51) |
| Upside | -49784.6% - -17582.1% | -25713.2% |